Clinical Trial Update: Letrozole in Metastatic Breast Cancer in Combination With Chemotherapy [Phase 2, Phase 3]

View source ↗

Summary

Phase 2/3 trial update on letrozole in combination with chemotherapy for metastatic breast cancer; the study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• FEMARA (letrozole)

Snippet

Sponsor: Novartis | Conditions: Metastatic Breast Cancer | Phase 2, Phase 3 | Status: COMPLETED